ALKS 8-K 2026-07-08

Alkermes plc. (ALKS) 8-K dated 2026-07-08 — accession 0001193125-26-298004. This URL is the filing, not the ALKS hub.

Alkermes plc. (ALKS) is a drug manufacturers - specialty & generic company listed on US.

Alkermes plc. filed a 8-K on 2026-07-08. Accession 0001193125-26-298004.

Cached items: 1.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALKS revenue for 2025-12-31 was $1.48B. Net income was $241.7M. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.

Not investment advice. The ALKS SEC hub lists recent forms. The stock page is the research view.